Secondary Logo

Journal Logo

November 1st, 2005 - Volume 40 - Issue 3
pp: 245-382


HIV-1 p24 May Persist During Long-Term Highly Active Antiretroviral Therapy, Increases Little During Short Treatment Breaks, and Its Rebound After Treatment Stop Correlates With CD4+ T Cell Loss

Schüpbach, Jörg; Günthard, Huldrych; Joos, Beda; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 40(3):250-256, November 1st, 2005.

Role of Lymphocyte Multidrug Resistance Protein 1 in HIV Infection: Expression, Function, and Consequences of Inhibition

Lucia, Mothanje Barbara; Savarino, Andrea; Straface, Elisabetta; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 40(3):257-266, November 1st, 2005.

Lack of Association of SDF-1 3′A Variant Allele With Long-Term Nonprogressive HIV-1 Infection Is Extended Beyond 16 Years

Vidal, Francesc; Peraire, Joaquim; Domingo, Pere; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 40(3):276-279, November 1st, 2005.


Lopinavir/Ritonavir as Single-Drug Therapy for Maintenance of HIV-1 Viral Suppression: 48-Week Results of a Randomized, Controlled, Open-Label, Proof-of-Concept Pilot Clinical Trial (OK Study)

Arribas, José R; Pulido, Federico; Delgado, Rafael; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 40(3):280-287, November 1st, 2005.

Discordant Immunologic and Virologic Responses to Highly Active Antiretroviral Therapy Are Associated With Increased Mortality and Poor Adherence to Therapy

Moore, David M; Hogg, Robert S; Yip, Benita; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 40(3):288-293, November 1st, 2005.

Four Measures of Antiretroviral Medication Adherence and Virologic Response in AIDS Clinical Trials Group Study 359

Fletcher, Courtney V; Testa, Marcia A; Brundage, Richard C; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 40(3):301-306, November 1st, 2005.

Structured Treatment Interruptions in Primary HIV-1 Infection: The ANRS 100 PRIMSTOP Trial

Hoen, Bruno; Fournier, Isabelle; Lacabaratz, Christine; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 40(3):307-316, November 1st, 2005.

Once-Daily Regimen of Saquinavir, Ritonavir, Didanosine, and Lamivudine in HIV-Infected Patients With Standard Tuberculosis Therapy (TBQD Study)

Ribera, Esteban; Azuaje, Carlos; Lopez, Rosa M; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 40(3):317-323, November 1st, 2005.


Clinical Science



Initial Response to Highly Active Antiretroviral Therapy in HIV-1C-Infected Adults in a Public Sector Treatment Program in Botswana

Wester, C William; Kim, Soyeon; Bussmann, Hermann; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 40(3):336-343, November 1st, 2005.

Effect of a Brief Antiretroviral Adherence Intervention Delivered by HIV Care Providers

Milam, Joel; Richardson, Jean L; McCutchan, Allen; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 40(3):356-363, November 1st, 2005.

Is Sexual Contact With Sex Workers Important in Driving the HIV Epidemic Among Men in Rural Zimbabwe?

Cowan, Frances M; Langhaug, Lisa F; Hargrove, John W; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 40(3):371-376, November 1st, 2005.


Impact of Coinfection With HIV-1 and GB Virus C in Patients Receiving a Ritonavir-Boosted HAART Regimen: A Substudy to the MaxCmin1 Trial

Tillmann, Hans L; Kaiser, Thorsten; Fox, Zoe; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 40(3):378-380, November 1st, 2005.

Show: